Why would a patient trust a peptide more than a statin? STAT BPC 157 is one of the most talked about peptides right now, and I understand the excitement. The preclinical research is genuinely interesting. Across animal models, BPC 157 appears to support tissue repair, angiogenesis, BPC 157 has 500 plus preclinical publications. Fewer than 30 humans in published trials. Across 30 years of research. A Phase I trial enrolled 42 people in 2015 and never published its results. Modulatory effects of BPC 157 on vasomotor tone and the activation of Src Caveolin 1 endothelial nitric oxide synthase pathway Scientific Reports Safety of Recombinant Activated Factor VII in Randomized Clinical Trials New England Journal of Medicine